BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11928809)

  • 1. Random peptide bacteriophage display as a probe for urokinase receptor ligands.
    Fong S; Doyle MV; Goodson RJ; Drummond RJ; Stratton JR; McGuire L; Doyle LV; Chapman HA; Rosenberg S
    Biol Chem; 2002 Jan; 383(1):149-58. PubMed ID: 11928809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoaffinity labeling of the human receptor for urokinase-type plasminogen activator using a decapeptide antagonist. Evidence for a composite ligand-binding site and a short interdomain separation.
    Ploug M; Ostergaard S; Hansen LB; Holm A; Danø K
    Biochemistry; 1998 Mar; 37(11):3612-22. PubMed ID: 9521680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site.
    Ploug M
    Biochemistry; 1998 Nov; 37(47):16494-505. PubMed ID: 9843416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.
    Franco P; Vocca I; Carriero MV; Alfano D; Cito L; Longanesi-Cattani I; Grieco P; Ossowski L; Stoppelli MP
    J Cell Sci; 2006 Aug; 119(Pt 16):3424-34. PubMed ID: 16882693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-step affinity purification of recombinant urokinase-type plasminogen activator receptor using a synthetic peptide developed by combinatorial chemistry.
    Jacobsen B; Gårdsvoll H; Juhl Funch G; Ostergaard S; Barkholt V; Ploug M
    Protein Expr Purif; 2007 Apr; 52(2):286-96. PubMed ID: 17027282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization of soluble urokinase receptor (suPAR) in complex with urokinase amino-terminal fragment (1-143).
    Huang M; Mazar AP; Parry G; Higazi AA; Kuo A; Cines DB
    Acta Crystallogr D Biol Crystallogr; 2005 Jun; 61(Pt 6):697-700. PubMed ID: 15930623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.
    Salasznyk RM; Zappala M; Zheng M; Yu L; Wilkins-Port C; McKeown-Longo PJ
    Matrix Biol; 2007 Jun; 26(5):359-70. PubMed ID: 17344041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble urokinase receptor promotes cell adhesion and requires tyrosine-92 for activation of p56/59(hck).
    Trigwell S; Wood L; Jones P
    Biochem Biophys Res Commun; 2000 Nov; 278(2):440-6. PubMed ID: 11097855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction.
    Høyer-Hansen G; Behrendt N; Ploug M; Danø K; Preissner KT
    FEBS Lett; 1997 Dec; 420(1):79-85. PubMed ID: 9450554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.
    Goodson RJ; Doyle MV; Kaufman SE; Rosenberg S
    Proc Natl Acad Sci U S A; 1994 Jul; 91(15):7129-33. PubMed ID: 8041758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy.
    Ploug M; Gårdsvoll H; Jørgensen TJ; Lønborg Hansen L; Danø K
    Biochem Soc Trans; 2002 Apr; 30(2):177-83. PubMed ID: 12023847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites.
    Gårdsvoll H; Werner F; Søndergaard L; Danø K; Ploug M
    Protein Expr Purif; 2004 Apr; 34(2):284-95. PubMed ID: 15003263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
    Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA
    FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of urokinase receptor interaction with Peptide antagonists studied by amide hydrogen exchange and mass spectrometry.
    Jørgensen TJ; Gårdsvoll H; Danø K; Roepstorff P; Ploug M
    Biochemistry; 2004 Nov; 43(47):15044-57. PubMed ID: 15554712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.
    Reuning U; Magdolen V; Hapke S; Schmitt M
    Biol Chem; 2003 Aug; 384(8):1119-31. PubMed ID: 12974381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anti-urokinase plasminogen activator receptor (uPAR) antibody: crystal structure and binding epitope.
    Li Y; Parry G; Chen L; Callahan JA; Shaw DE; Meehan EJ; Mazar AP; Huang M
    J Mol Biol; 2007 Jan; 365(4):1117-29. PubMed ID: 17101149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. uPA-silica-Particles (SP-uPA): a novel analytical system to investigate uPA-uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeutics.
    Guthaus E; Bürgle M; Schmiedeberg N; Hocke S; Eickler A; Kramer MD; Sweep CG; Magdolen V; Kessler H; Schmitt M
    Biol Chem; 2002 Jan; 383(1):207-16. PubMed ID: 11930939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of integrin alpha M beta 2 ligand-binding function by the urokinase-type plasminogen activator receptor.
    Tang ML; Kong LS; Law SK; Tan SM
    Biochem Biophys Res Commun; 2006 Sep; 348(3):1184-93. PubMed ID: 16905120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1.
    Kanse SM; Chavakis T; Al-Fakhri N; Hersemeyer K; Monard D; Preissner KT
    J Cell Sci; 2004 Jan; 117(Pt 3):477-85. PubMed ID: 14679304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of urokinase-type plasminogen activator receptor is correlated with metastases of lingual squamous cell carcinoma.
    Wang J; Guo F; Wei H; Dong J; Wu J
    Br J Oral Maxillofac Surg; 2006 Dec; 44(6):515-9. PubMed ID: 16356605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.